Alpha DNA Investment Management LLC Makes New $392,000 Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Alpha DNA Investment Management LLC purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,949 shares of the company’s stock, valued at approximately $392,000.

A number of other large investors also recently made changes to their positions in ADUS. UMB Bank n.a. raised its position in shares of Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the period. Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $31,000. EntryPoint Capital LLC acquired a new stake in shares of Addus HomeCare during the first quarter valued at about $44,000. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $44,000. Finally, Farther Finance Advisors LLC grew its stake in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling

In other news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 12.93 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 4.60% of the company’s stock.

Addus HomeCare Trading Up 2.9 %

ADUS stock opened at $124.32 on Monday. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12. The company has a fifty day simple moving average of $128.25 and a 200 day simple moving average of $123.29. The firm has a market cap of $2.25 billion, a PE ratio of 28.45, a PEG ratio of 2.11 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.03 EPS. As a group, analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ADUS shares. Oppenheimer raised their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Stephens lifted their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. TD Cowen raised their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.